Viewing Study NCT03874234


Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2026-03-05 @ 2:32 PM
Study NCT ID: NCT03874234
Status: TERMINATED
Last Update Posted: 2023-02-27
First Post: 2019-03-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability and Pharmacokinetics (PKs) Investigation of GSK3186899 in Healthy Subjects
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leishmaniasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose escalation phase View
None First time in human View
None Single ascending dose View
None Multiple ascending dose View
None GSK3186899 View